Attributable Mortality of Nosocomial Candidemia, Revisited
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These infections are associated with attributable mortality rates that have ranged from 38% between 1983 and 1986 (46) to 49% in the same institutions between 1997 and 2001 (13).”
In the citing paper
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in controls; the resulting ''attributable mortality'' was therefore estimated to be 49%.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [12]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Research works printed but not linked: 3
- Harvey, 1987, Archives of Internal Medicine, 147, 2117, 10.1001/archinte.1987.00370120053011 · doi:10.1001/archinte.1987.00370120053011
- Martin, 1989, Annals of Internal Medicine, 110, 9, 10.1059/0003-4819-110-1-9 · doi:10.1059/0003-4819-110-1-9
- O'Grady, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 51, 1
Cited by
Items 101–200 of 1,000
The Changing Face of Fungal Infections in Health Care Settings
Weinstein, R. A., & Fridkin, S. K. (2005) · Clinical Infectious Diseases · doi:10.1086/497138 · Cited by 171
Epidemiology of Candidemia in a Tertiary Care Centre of North India: 5-Year Study
Xess, I., Jain, N., Hasan, M. F., Mandal, P., & Banerjee, U. (2007) · Infection · doi:10.1007/s15010-007-6144-6 · Cited by 170
Candida albicans Infection of Caenorhabditis elegans Induces Antifungal Immune Defenses
Pukkila-Worley, R., Ausubel, F. M., & Mylonakis, E. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002074 · Cited by 170
Lin, M., Carmeli, Y., Zumsteg, J. M., Flores, E., Tolentino, J., Sreeramoju, P., & Weber, S. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4555-4560.2005 · Cited by 169
Fungi inhabiting the healthy human gastrointestinal tract: a diverse and dynamic community
Hallen-Adams, H. E., Kachman, S. D., Kim, J., Legge, R. M., & Martínez, I. (2015) · Fungal Ecology · doi:10.1016/j.funeco.2015.01.006 · Cited by 165
Louie, A., Deziel, M., Liu, W., Drusano, M. F., Gumbo, T., & Drusano, G. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5058-5068.2005 · Cited by 164
Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 164
Risk factors for invasive fungal disease in critically ill adult patients: a systematic review
Muskett, H., Shahin, J., Eyres, G., Harvey, S. E., Rowan, K., & Harrison, D. A. (2011) · Critical Care · doi:10.1186/cc10574 · Cited by 164
Colombo, A. L., Guimarães, T., Silva, L. R. B. F., Monfardini, L. P. D. A., Cunha, A. K. B., Rady, P., Alves, T., & Rosas, R. C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/513615 · Cited by 162
Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?
Leventakos, K., Lewis, R. E., & Kontoyiannis, D. P. (2010) · Clinical Infectious Diseases · doi:10.1086/649879 · Cited by 162
Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
Self-citationOstrosky-Zeichner, L., Shoham, S., Vazquez, J., Reboli, A., Betts, R., Barron, M. A., Schuster, M., Judson, M. A., Revankar, S. G., Caeiro, J. P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu074 · Cited by 160
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
Plantinga, T. S., Johnson, M. D., Scott, W. K., van de Vosse, E., Velez Edwards, D. R., Smith, P. B., Alexander, B. D., Yang, J. C., Kremer, D., Laird, G. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir867 · Cited by 141
Wenzel, R. P., & Gennings, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430923 · Cited by 159
Eggimann, P., & Pittet, D. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3355-z · Cited by 140
Gazendam, R. P., van de Geer, A., Roos, D., van den Berg, T. K., & Kuijpers, T. W. (2016) · Immunological Reviews · doi:10.1111/imr.12454 · Cited by 159
Pierce, C. G., & Lopez-Ribot, J. L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.807245 · Cited by 158
Diagnosis of invasive candidiasis in the ICU
Eggimann, P., Billé, J., & Marchetti, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-37 · Cited by 158
Das, I., Nightingale, P., Patel, M., & Jumaa, P. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.06.006 · Cited by 137
Temporal analysis of Candida albicans gene expression during biofilm development
Yeater, K. M., Chandra, J., Cheng, G., Mukherjee, P. K., Zhao, X., Rodriguez-Zas, S. L., Kwast, K. E., Ghannoum, M. A., & Hoyer, L. L. (2007) · Microbiology · doi:10.1099/mic.0.2007/006163-0 · Cited by 140
Quan, H., Cao, Y., Xu, Z. Q., Zhao, J.-X., Gao, P., Qin, X., & Jiang, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1096-1099.2006 · Cited by 157
Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations
Smith, J., & Andes, D. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318167d0e0 · Cited by 156
Current Trends and Potential Applications of Microbial Interactions for Human Welfare
Tshikantwa, T. S., Ullah, M. W., He, F., & Yang, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01156 · Cited by 156
Oberoi, J. K., Wattal, C., Goel, N., Raveendran, R., Datta, S., & Prasad, K. (2012) · PubMed Central · Cited by 154
Pitarch, A., Jiménez, A., Nombela, C., & Gil, C. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500243-mcp200 · Cited by 150
González, G. M., Elizondo-Zertuche, M., & Ayala, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00937-08 · Cited by 149
Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., & Ghannoum, M. A. (2007) · Infection and Immunity · doi:10.1128/iai.01841-06 · Cited by 130
Ruhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 148
Genetics of Candida albicans, a Diploid Human Fungal Pathogen
Noble, S. M., & Johnson, A. D. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.042007.170146 · Cited by 147
Tierney, L., Linde, J., Müller, S., Brunke, S., Molina, J. C., Hube, B., Schöck, U., Guthke, R., & Kuchler, K. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00085 · Cited by 144
Luo, S., Poltermann, S., Kunert, A., Rupp, S., & Zipfel, P. F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.07.017 · Cited by 143
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 142
Antifungal serum concentration monitoring: an update
Goodwin, M. L., & Drew, R. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm389 · Cited by 141
Klingspor, L., Tortorano, A. M., Peman, J., Willinger, B., Hamal, P., Sendid, B., Velegraki, A., Kibbler, C., Meis, J. F., Sabino, R., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.08.011 · Cited by 137
“Candidaemia is associated with significant morbidity [10].”
BackgroundMolecular Epidemiology of Candidemia: Evidence of Clusters of Smoldering Nosocomial Infections
Ásmundsdóttir, L. R., Erlendsdóttir, H., Haraldsson, G., Guo, H., Xu, J., & Gottfredsson, M. (2008) · Clinical Infectious Diseases · doi:10.1086/589298 · Cited by 117
Chamilos, G., Lionakis, M. S., Lewis, R. E., Lopez-Ribot, J. L., Saville, S. P., Albert, N. D., Halder, G. A., & Kontoyiannis, D. P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500950 · Cited by 136
Orasch, C., Marchetti, O., Garbino, J., Schrenzel, J., Zimmerli, S., Mühlethaler, K., Pfyffer, G. E., Ruef, C., Fehr, J. S., Zbinden, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12440 · Cited by 134
Ostrosky-Zeichner, L., Pappas, P. G., Shoham, S., Reboli, A., Barron, M. A., Sims, C., Wood, C., & Sobel, J. D. (2011) · Mycoses · doi:10.1111/j.1439-0507.2009.01756.x · Cited by 121
Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis
Lopes da Rosa, J., Boyartchuk, V. L., Zhu, L. J., & Kaufman, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912427107 · Cited by 132
Insights into Candida tropicalis nosocomial infections and virulence factors
Negri, M., Silva, S., Henriques, M., & Oliveira, R. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1455-z · Cited by 132
“Nosocomial infections (NIs), or in other words hospital acquired infections, are now a serious public health problem, since these infections are among the leading causes of morbidity and mortality, causing an increase in hospitalization time and, consequently, high costs associated to patient’s treatment [1, 2].”
BackgroundLau, A. F., Halliday, C. L., Chen, S. C.-A., Playford, E. G., Stanley, K. K., & Sorrell, T. C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01650-09 · Cited by 132
Tumor Necrosis Factor Inhibition and Invasive Fungal Infections
Filler, S. G., Yeaman, M. R., & Sheppard, D. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430000 · Cited by 130
Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121
Strollo, S., Lionakis, M. S., Adjemian, J., Steiner, C. A., & Prevots, D. R. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2301.161198 · Cited by 129
Mokaddas, E. M., Al‐Sweih, N., & Khan, Z. U. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46817-0 · Cited by 129
Effect of antifungal therapy timing on mortality in cancer patients with candidemia
Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A., & Seo, S. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00945-09 · Cited by 127
Salmanton-García, J., Cornely, O. A., Stemler, J., Barać, A., Steinmann, J., Siváková, A., Akalin, E. H., Arikan-Akdagli, S., Loughlin, L., Toscano, C., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106229 · Cited by 127
Prasath, K. G., Tharani, H., Kumar, M. S., & Pandian, S. K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00864 · Cited by 127
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia
Sobel, J. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0016-6 · Cited by 127
Aníbal, P. C., Peixoto, I. T. A., Foglio, M. A., & Höfling, J. F. (2013) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822013005000060 · Cited by 126
A first Portuguese epidemiological survey of fungaemia in a university hospital
Costa‐de‐Oliveira, S., Pina‐Vaz, C., Mendonça, D. M., & Rodrigues, A. G. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0448-4 · Cited by 126
Secreted aspartic proteases of Candida albicans activate the NLRP 3 inflammasome
Pietrella, D., Pandey, N., Gabrielli, E., Pericolini, E., Perito, S., Kasper, L., Bistoni, F., Cassone, A., Hube, B., & Vecchiarelli, A. (2013) · European Journal of Immunology · doi:10.1002/eji.201242691 · Cited by 110
Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity
Tang, J., Lin, G., Langdon, W. Y., Tao, L., & Zhang, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00123 · Cited by 125
Pierce, C. G., Chaturvedi, A. K., Lazzell, A. L., Powell, A. T., Saville, S. P., McHardy, S. F., & Lopez-Ribot, J. L. (2015) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2015.12 · Cited by 124
Invasive candidiasis in immunocompromised hospitalized patients.
Sims, C. R., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.05.015 · Cited by 124
Grim, S. A., Berger, K., Teng, C. B., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 124
Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida
Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5729-5731.2003 · Cited by 123
Self-citationRegulation of Candida albicans Hyphal Morphogenesis by Endogenous Signals
Kornitzer, D. (2019) · Journal of Fungi · doi:10.3390/jof5010021 · Cited by 121
Fisiopatogenia, epidemiologia e diagnóstico laboratorial da candidemia
Giolo, M. P., & Svidzinski, T. I. E. (2010) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442010000300009 · Cited by 121
Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00680-13 · Cited by 120
Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 120
Mejía-Chew, C., O’Halloran, J. A., Olsen, M. A. A., Stwalley, D. L., Kronen, R., Lin, C., Salazar, A. S., Larson, L., Hsueh, K., Powderly, W. G., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30405-0 · Cited by 120
Role of TLR1 and TLR6 in the host defense against disseminated candidiasis
Netea, M. G., van de Veerdonk, F. L., Verschueren, I., van der Meer, J. W. M., & Kullberg, B. J. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00353.x · Cited by 119
Arastehfar, A. A., Daneshnia, F., Polat, S. H., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., İlkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 119
Thangamani, S., Eldesouky, H. E., Mohammad, H. T., Pascuzzi, P. E., Avramova, L. V., Hazbun, T. R., & Seleem, M. N. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.029 · Cited by 119
Multilocus sequence typing of Candida albicans: strategies, data exchange and applications
Bougnoux, M., Aanensen, D. M., Morand, S., Théraud, M., Spratt, B. G., & d’Enfert, C. (2004) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2004.06.002 · Cited by 118
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfreðsson, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02566-12 · Cited by 115
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
Bassetti, M., Righi, E., Montravers, P., & Cornely, O. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx445 · Cited by 116
Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry
Marinach, C., Fekkar, A., Atanasova, R., Gomes, J., Djamdjian, L., Brossas, J., Meyer, I., Buffet, P. A., Snounou, G., Datry, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008862 · Cited by 114
Candida albicans Dispersed Cells Are Developmentally Distinct from Biofilm and Planktonic Cells
Uppuluri, P., Acosta Zaldívar, M., Anderson, M. Z., Dunn, M. J., Berman, J., Lopez Ribot, J. L., & Köhler, J. R. (2018) · mBio · doi:10.1128/mbio.01338-18 · Cited by 107
Xu, Y., Wang, Y., Yan, L., Liang, R.-M., Dai, B.-D., Tang, R.-J., Gao, P.-H., & Jiang, Y.-Y. (2009) · Journal of Proteome Research · doi:10.1021/pr9005074 · Cited by 113
Mellinghoff, S. C., Hoenigl, M., Koehler, P. A., Kumar, A., Lagrou, K., Lass‐Flörl, C., Meis, J. F. G. M., Menon, V. P., Rautemaa‐Richardson, R., & Cornely, O. A. (2018) · Mycoses · doi:10.1111/myc.12746 · Cited by 113
Treatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 113
Dimopoulos, G., Karabinis, A., Samonis, G., & Falagas, M. E. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0316-2 · Cited by 97
Human inborn errors of immunity underlying superficial or invasive candidiasis
Puel, A. (2020) · Human Genetics · doi:10.1007/s00439-020-02141-7 · Cited by 109
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 109
Weinberger, M., Leibovici, L., Perez, S., Samra, Z., Ostfeld, I., Levi, I., Bash, E., Turner, D., Goldschmied‐Reouven, A., Regev‐Yochay, G., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.02.009 · Cited by 109
Legrand, M., Chan, C. L., Jauert, P. A., & Kirkpatrick, D. T. (2007) · Eukaryotic Cell · doi:10.1128/ec.00299-07 · Cited by 98
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 107
Time to positive culture and identification for Candida blood stream infections
Fernandez, J., Erstad, B. L., Petty, W., & Nix, D. E. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.04.002 · Cited by 106
Magill, S. S., Swoboda, S. M., Johnson, E. A., Merz, W. G., Pelz, R. K., Lipsett, P. A., & Hendrix, C. W. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.03.013 · Cited by 106
Pathogenesis of invasive candidiasis
van de Veerdonk, F. L., Kullberg, B. J., & Netea, M. G. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e046e · Cited by 106
Khot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., & Tyler, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-06 · Cited by 104
“The prognosis for BSI caused by Candida species is poor, with an attributable mortality for nosocomial BSI of nearly 50% (34).”
BackgroundEpidemiology of Candida Bloodstream Infections in a Tertiary Care Institute in India
Kothari, A., & Sagar, V. (2009) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.49440 · Cited by 104
Le, H. T., Tran, V. G., Kim, W., Kim, J., Cho, H. R., & Kwon, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103564 · Cited by 104
The Tetraspanin Protein CD37 Regulates IgA Responses and Anti-Fungal Immunity
van Spriel, A. B., Sofi, M., Gartlan, K. H., van der Schaaf, A., Verschueren, I., Torensma, R., Raymakers, R. A. P., Loveland, B. E., Netea, M. G., Adema, G. J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000338 · Cited by 102
da Matta, D. A., de Almeida, L. P., Machado, A. M. D. O., Azevedo, A. C., Kusano, E. J. U., Travassos, N. F., Salomão, R., & Colombo, A. L. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.011 · Cited by 102
Vazquez, J., Reboli, A. C., Pappas, P. G., Patterson, T. F., Reinhardt, J., Chin-Hong, P., Tobin, E., Kett, D. H., Biswas, P., & Swanson, R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-97 · Cited by 101
Strategies to Prevent Transmission of Candida auris in Healthcare Settings
Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 100
Paiva, J.-A., Pereira, J. M., Tabah, A., Mikstacki, A., de Carvalho, F. B., Koulenti, D., Ruckly, S., Çakar, N., Misset, B., Dimopoulos, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1229-1 · Cited by 100
Jaeger, M., van der Lee, R., Cheng, S., Johnson, M. D., Kumar, V., Ng, A., Plantinga, T. S., Smeekens, S. P., Oosting, M., Wang, X., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2309-2 · Cited by 99
Golan, Y., Wolf, M. P., Pauker, S. G., Wong, J. B., & Hadley, S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00004 · Cited by 98
Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp
Messer, S. A., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J., & Pfaller, M. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.324-326.2006 · Cited by 97
Self-citationUpdate on the optimal use of voriconazole for invasive fungal infections
Thompson, G. R., & Lat (2011) · Infection and Drug Resistance · doi:10.2147/idr.s12714 · Cited by 97
Frank, C. F., & Hostetter, M. K. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.006 · Cited by 97
Preventing invasive candida infections. Where could we do better?
Eggimann, P., Que, Y., Revelly, J., & Pagani, J. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.11.006 · Cited by 97
Candidemia and invasive candidiasis: A review of the literature for the burns surgeon
Ha, J. F., Italiano, C. M., Heath, C. H., Shih, S., Rea, S. M., & Wood, F. M. (2010) · Burns · doi:10.1016/j.burns.2010.01.005 · Cited by 97
An overview of antifungal peptides derived from insect
Faruck, M. O., Yusof, F., & Chowdhury, S. (2015) · Peptides · doi:10.1016/j.peptides.2015.06.001 · Cited by 96
Chaillot, J., Tebbji, F., Remmal, A., Boone, C., Brown, G. W., Bellaoui, M., & Sellam, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00551-15 · Cited by 96
Emergence of non-albicans candida species in neonatal candidemia
Juyal, D., Sharma, M., Pal, S., Rathaur, V., & Sharma, N. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.118919 · Cited by 84
RAAD, I. I., Jamal, M. A., Reitzel, R. A., Jiang, Y., Raad, S., Shuaibi, M. A., Chaftari, A., & Hachem, R. Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05836-11 · Cited by 96
Metadata
- Authors
- Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Iowa (US)
- Corresponding author
- Diekema, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1172-1177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2118236446
- Cited by
- 1,140
- References
- 37
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 22 · 2023: 30 · 2022: 35 · 2021: 34 · 2020: 35 · 2019: 38 · 2018: 35 · 2017: 51 · 2016: 41 · 2015: 59 · 2014: 74 · 2013: 76 · 2012: 60
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial candidemia, attributable mortality, candidemia, mortality, matched case-control comparison, underlying disease, risk factors, nosocomial infections
- MeSH terms
- Age Factors, Antifungal Agents, Candida, Candidiasis, Cross Infection, Female, Humans, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Sex Factors, Cohort Studies, Fluconazole, Survival Rate, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.